Search Results

There are 17752 results for: content related to: Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma

  1. Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1674–1684, Dr Ahmad Awada, Dr Thierry Gil, Dr Nicolas Whenham, Dr Julie Van Hamme, Dr Tatiana Besse-Hammer, Dr Erich Brendel, Dr Heinz Delesen, Dr Miranda C. Joosten, Dr Chetan D. Lathia, Dr Bienvenu A. Loembé, Dr Martine Piccart-Ghebart and Dr Alain Hendlisz

    Version of Record online : 12 MAR 2013, DOI: 10.1177/0091270010386226

  2. Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 656–669, Dr Einat Shacham-Shmueli, Dr Ravit Geva, Dr Arie Figer, Dr Sarah Bulocinic, Dr Karen Nalbandyan, Dr Shulim Shpigel, Dr Jacob Atsmon and Dr Erich Brendel

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011404027

  3. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  4. You have free access to this content
    Sorafenib rechallenge in patients with metastatic renal cell carcinoma

    BJU International

    Volume 110, Issue 6b, September 2012, Pages: E228–E234, Masahiro Nozawa, Yutaka Yamamoto, Takafumi Minami, Nobutaka Shimizu, Yuji Hatanaka, Hidenori Tsuji and Hirotsugu Uemura

    Version of Record online : 14 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10905.x

  5. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma

    Pediatric Blood & Cancer

    Volume 58, Issue 4, April 2012, Pages: 539–544, Irene Schmid, Beate Häberle, Michael H. Albert, Selim Corbacioglu, Birgit Fröhlich, Norbert Graf, Birgit Kammer, Udo Kontny, Ivo Leuschner, Hans-Gerhard Scheel-Walter, Wolfram Scheurlen, Sebastian Werner, Thomas Wiesel and Dietrich von Schweinitz

    Version of Record online : 15 SEP 2011, DOI: 10.1002/pbc.23295

  6. You have free access to this content
    The Adverse Effects of Sorafenib in Patients with Advanced Cancers

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 3, March 2015, Pages: 216–221, Ye Li, Zu-Hua Gao and Xian-Jun Qu

    Version of Record online : 14 JAN 2015, DOI: 10.1111/bcpt.12365

  7. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

    British Journal of Dermatology

    Volume 161, Issue 5, November 2009, Pages: 1045–1051, W.J. Lee, J.L. Lee, S.E. Chang, M.W. Lee, Y.K. Kang, J.H. Choi, K.C. Moon and J.K. Koh

    Version of Record online : 5 MAY 2009, DOI: 10.1111/j.1365-2133.2009.09290.x

  8. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

    Hepatology Research

    Volume 42, Issue 6, June 2012, Pages: 523–542, Shuichi Kaneko, Junji Furuse, Masatoshi Kudo, Kenji Ikeda, Masao Honda, Yasunari Nakamoto, Morikazu Onchi, Goshi Shiota, Osamu Yokosuka, Isao Sakaida, Tetsuo Takehara, Yoshiyuki Ueno, Kazumasa Hiroishi, Shuhei Nishiguchi, Hisataka Moriwaki, Kazuhide Yamamoto, Michio Sata, Shuntaro Obi, Shiro Miyayama and Yukinori Imai

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1872-034X.2012.00981.x

  9. Meta-analysis of dermatological toxicities associated with sorafenib

    Clinical and Experimental Dermatology

    Volume 36, Issue 4, June 2011, Pages: 344–350, L. Zhang, Q. Zhou, L. Ma, Z. Wu and Y. Wang

    Version of Record online : 20 APR 2011, DOI: 10.1111/j.1365-2230.2011.04060.x

  10. You have free access to this content
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

    Hepatology

    Volume 54, Issue 6, December 2011, Pages: 2055–2063, Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, Claudio Zavaglia, Antonio Grieco, Erica Villa, Calogero Cammà, Massimo Colombo and on behalf of the SOFIA (SOraFenib Italian Assessment) study group

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24644

  11. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  12. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1463–1469, Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Soo Young Park, Ja Kyung Kim, Hyun Woong Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Young Oh Kweon, Jung Il Lee, Kwan Sik Lee, Hyung Joon Kim and Kwang-Hyub Han

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12542

  13. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  14. Effects of Antitumor Drug Sorafenib on Chick Embryo Development

    The Anatomical Record

    Volume 298, Issue 7, July 2015, Pages: 1271–1281, Yi-Sen Cheng, Xiao-Yu Wang, Guang Wang, Yan Li, Yue-Lei Chen, Man-li Chuai, Kenneth Ka Ho Lee, Xiao-Yan Ding and Xue-song Yang

    Version of Record online : 17 APR 2015, DOI: 10.1002/ar.23155

  15. Hyperkeratotic eruption, hand–foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib

    International Journal of Dermatology

    Volume 49, Issue 10, October 2010, Pages: 1203–1206, Seema Sahai and Brian L. Swick

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1365-4632.2010.04606.x

  16. Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation

    Clinical Transplantation

    Volume 27, Issue 4, July/August 2013, Pages: 555–561, Abhijeet Waghray, Bengi Balci, Galal El-Gazzaz, Richard Kim, Robert Pelley, KV Narayanan Menon, Bassam Estfan, Carlos Romero-Marrero and Federico Aucejo

    Version of Record online : 13 JUN 2013, DOI: 10.1111/ctr.12150

  17. Sorafenib-induced premalignant and malignant skin lesions

    International Journal of Dermatology

    Volume 50, Issue 4, April 2011, Pages: 396–402, Victoria L. Williams, Philip R. Cohen and David J. Stewart

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1365-4632.2010.04822.x

  18. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  19. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  20. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Version of Record online : 10 JUN 2014, DOI: 10.1111/bph.12659